Drawing for CREATIVE BIOMART

USPTO serial 90384393

CREATIVE BIOMART

Reviewed by CopyMark Law Group

Reg. 6515330Status 700Renewal
Filing date
Status date
Registration date
Oct 12, 2021
Examiner
FLEMING, STEPHANIE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CREATIVE BIOMART?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $325

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David Lin

1001 162ND ST4DWHITESTONE, NY 11357

Goods and services

ClassDescriptionStatusFirst use
042Bacteriological consultation and research; Bacteriological research and testing; Biochemical research and development; Biological research; Biomedical research services; Biotechnology research; Chemical analysis; Chemical engineering; Chemical laboratories; Chemical research; Chemical, biochemical, biological and bacteriological research and analysis; Chemist services; Chemistry consultation; Compiling data for research purposes in the field of medical science and medical consultancy; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Custom design and development of chemical reagents and biochemical assays; Design and testing of new products for others; Design, engineering, research, development and testing services in the field of polymeric materials, polymer synthesis, and materials customization for medical, scientific, and technological applications; Development and test of chemical production methods; Development of pharmaceutical preparations and medicines; DNA analysis services for scientific research purposes; Drug discovery services; Executing of chemical analyses; Genetic mapping for scientific purposes; Genetic testing for scientific research purposes; Genetic testing of laboratory animals for research purposes; Laboratory analysis in the field of bacteriology, chemistry, and cosmetics; Laboratory research services relating to pharmaceuticals; Laboratory services, namely, pigment and color analysis; Medical laboratory services; Medical research; Medical research services in the field of cancer; Medical and scientific research information in the field of drug discovery; Medical and scientific research in the field of cancer treatment and diagnosis; Performance of chemical analyses; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research services; Pharmaceutical research and development; Product testing; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; Research and development in the field of drug discovery; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of new products for others; Research and development of technology in the field of drug discovery; Research in the field of chemistry; Research on the subject of pharmaceuticals; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific investigations for medical purposes; Scientific laboratory services; Scientific research; Scientific research and development; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of drug discovery, medicine, the prevention, treatment and management of illness, health care delivery, and cancerous diseases; Scientific research in the field of genetics and genetic engineeringACTIVEJun 1, 2020

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 12, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Oct 12, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 27, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 27, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 7, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 24, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 24, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Jun 24, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 24, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 24, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 7, 2021DOCKASSIGNED TO EXAMINER—
Feb 25, 2021MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Feb 24, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 18, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance